Towards Tailored Dialysis Fluids in Capd the Role of Reduced Calcium and Magnesium in Dialysis Fluids

Malluche H. , Faugere M. Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 1990; 38: 193–211.

Gokal R. , Ramos J. , Ellis H. Histological renal osteodystrophy, and 25-hydroxycholecalciferol and aluminium levels in patients on CAPD. Kidney 1983; 23: 15–21.

Cassidy M. , Owen J. , Ellis H. Renal osteodystrophy and metastatic calcification in long term CAPD. Q J Med 1983; 213: 29–48.

Rahman R. , Heaton A. , Goodship T. Renal osteodystrophy in patients on CAPD: A five year study. Perit Dial Bull 1987; 7: 1–4.

Delmez J. , Fallon M. , Bergfeld M. , Gearing B. , Dougan C. , Teitelbaum S. Continuous ambulatory peritoneal dialysis and bone. Kidney Int 1986; 30: 379–84.

Nilsson P. , Danielsson B. , Grefbers N. , Wide L. Secondary hyperparathyroidism in diabetic and nondiabetic patients on long term CAPD. Scand J Urol Nephrol 1985; 19: 59–65.

Digenis G. , Khanna R. , Pierratos A. Renal osteodystrophy in patients managed on CAPD for more than three years. Perit Dial Bull 1983; 3: 81–6.

Kurtz S. Clinical parameters of renal bone disease: A comparison of CAPD and haemodialysis. Dial Transplant 1985; 14: 30–6.

Bucciante G. , Biachi M. , Valenti G. Progress of renal osteodystrophy during CAPD. Clin Nephrol 1984; 6: 279–83.

Holick M. Vitamin D and the kidney. Kidney Int 1987; 32: 912–29.

Lee D. , Brautbar N. , Kleeman C. Disorders of phosphorus metabolism. In: Bronner F. , Coburn J. , eds. Disorders of mineral metabolism pathophysiology of calcium, phosphorus and magnesium. New York: Academic Press, 1981: 283–421; vol 3.

Blumenkrantz M. , Kopple J. , Moran J. , Coburn J. Metabolic balance studies and dietary protein requirements in patients undergoing CAPD. Kidney Int 1982; 21: 849–861.

Lindholm B. , Bergstrom J. Nutritional aspects of CAPD. In: Gokal R. , ed. Continuous ambulatory peritoneal dialysis. Edinburgh: Churchill Livingstone, 1986: 228–55.

Nolph K. , Prowant B. , Serkes K. Multicenter evaluation of a new peritoneal dialysis solution with a high lactate and low magnesium concentration. Perit Dial Bull 1983; 3: 63–5.

Hercz G. , Coburn J. Prevention of phosphate retention and hyperphosphatemia in uremia. Kidney Int 1987; 32(Suppl 22) S215–20.

Martis L. , Serkes K. , Nolph K. Calcium carbonate as a phosphate binder: Is there a need to adjust peritoneal calcium concentrations for patients using calcium carbonate? Perit Dial Int 1989; 9: 325–28.

de Broe M. , D'Hasse P. , Elseviers M. , Clement J. , Visser W. , van de Vyver F. Aluminium and end-stage renal failure. In: Davidson A. , ed. Nephrology: proceedings of the tenth ICN. Cambridge: Balliere Tindall, 1988: 1086–116; vol2.

Andreoli S. , Briggs J. , Junor B. Aluminium intoxication from aluminium-containing phosphate binders in children with azotemia not undergoing dialysis. New Engl J Med 1984; 310: 1079–4.

Ott S. Aluminium accumulation in individuals with normal renal function. Am J Kidney Dis 1985; 4: 297, 301.

Joffe P. , Olsen F. , Heaf J. , Gammelgaard B. , Pondephant J. Aluminium concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis. Clin Nephrol 1989; 32(3): 133–8.

Ramirez J. , Emmett M. , White M. The absorption of dietary phosphorus and calcium in haemodialysis patients. Kidney Int 1986; 30: 753–9.

Jespersen B. , Jensen J. , Nielsen H. Comparison of calcium carbonate and aluminium hydroxide as phosphate binders on biochemical bone markers, PTH (1–84), and bone mineral content in dialysis patients. Nephrol Dial Transplant 1991; 6: 98–104.

Sheikh M. , Maquire J. , Emmett M. Reduction of dietary phosphorus absorption binders. A theoretical, in vitro, and in vivo study. J Clin Invest 1989; 83: 6673.

Saluskyl , Coburn J. , Foley J. , Nelson P. , Fine R. Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminium levels after discontinuation of aluminium-containing gels in children receiving dialysis. J Pediatr 1986; 108: 767–70.

Slatopolsky E. , Weerts C. , Lopez -Hilker S. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. New Engl J Med 1986; 315: 157–61.

Stein H. , Yudis M. , Sirota R. Calcium carbonate as a phosphate binder. New Engl J Med 1987; 316: 109–10.

Saunders D. , Sillery J. , Chapman R. Effect of calcium carbonate and aluminium hydroxide on human intestinal function. Digest Dis Sci 1988; 33: 409–13.

Slatopolsky E. , Weerts C. , Norwood K. Long-term effects of calcium carbonate and 2.5 mEq/liter calcium dialysate on mineral metabolism. Kidney Int 1989; 36: 897–03.

Bowers G. , Brassard C. , Sena F. Measurement of ionized calcium in serum with ion-selective electrodes: A mature technology that can meet the daily service needs. Clin Chem 1986; 32(8): 1437–47.

Parker A. , Nolph K.M. Magnesium and calcium transfer during continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 1980; 26: 194–96.

Kwong M. , Lee J. , Chan M. Transperitoneal calcium and magnesium transfer during an eight-hour dialysis. Perit Dial Bull 1987; 7: 85–89.

Van der Merwe W. , Rodger R. , Grant A. Low calcium dialysate and high-dose oral calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis patients Nephrol Dial Transplant 1990; 5: 874–7.

Sawyer N. , Noonan K. , Altmann P. , Marsh F. , Cunningham J. High-dose calcium carbonate with stepwise reduction in dialysate calcium concentration: Effective phosphate control and aluminium avoidance in haemodialysis patients. Nephrol Dial Transplant 1988; 3: 1–5.

Brown A. , Finch J. , Lopez-Hilker S. New active analogues of vitamin D with low calcemic activity. Kidney Int 1990; 38(Suppl 29): S22–7.

Demontis R. , Westeel B. , Boudalliez B. One alpha hydroxyvitamin D3 increases plasma aluminum in hemodialyzed patients taking Al(OH)3. Kidney Int 1988; 33(Suppl 24): S175–7.

Demontis R. , Reissi D. , Noel C. Indirect clinical evidence that one alpha hydroxyvitamin D3 increases plasma aluminum in hemodialyzed patients taking aluminum hydroxide. Kidney Int 1989; 31: 123–27.

Burnakowska-Heldin M. , Doyle T. , Eadie M. , Mayor G. 1,25(OH)2 vitamin D3 increases serum and tissue accumulation of aluminum in rats. J Lab Clin Invest 1986; 108: 96–102.

Hutchison A. , Freemont A. , Lumb G. , Gokal R. Renal osteodystrophy in continuous ambulatory peritoneal dialysis. In: Khanna R. , ed. Advances in peritoneal dialysis. University of Toronto Press, 1991: 237–9; vol 7.

Hutchison A. , Gokal R. Calcium carbonate and low calcium dialysate in CAPD (Abstract). Nephrol Dial Transplant 1991; 6(3): 224.

Nolph K. , Sorkin M. , Rubin J. Continuous ambulatory peritoneal dialysis: Three-year experience at one center. Ann Intern Med 1980; 92: 609–13.

Piraino B. , Bernadini J. , Perlmutter J. , Holley J. , Johnson J. 2.5 mEq/L Ca dialysate and CaCO3 vs 3.5 mEq/L Ca dialysate and aluminum in PD patients. Perit Dial Int 1991; 11(Suppl 1): 208.

Lefebvre A. , de Vernejoul M. , Geuris J. , Goldfarb B. , Graulet A. , Morieux C. Optimal correction of acidosis changes progression of dialysis osteodystrophy. Kidney Int 1989; 36: 1112–8.

Cunningham J. , Beer J. , Coldwell R. , Noonan K. , Sawyer N. , Makin H. Dialysate calcium reduction in CAPD patients treated with calcium carbonate and alfacalcidol. Nephrol Dial Transplant 1991: in press.

Hercz G. , Pei Y. , Manuel A. Aplastic osteodystrophy without aluminum staining in dialysis patients (Abstract). Kidney Int 1990; 37: 449.

Gokal R. , Fryer R. , McHugh M. Calcium and phosphate control in CAPD patients. In: Legrain M. , ed. Excerpta medica. Amsterdam, 1980: 283–91.

Gonella M. , Ballanti P. , Della Rocca C. Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patients. Miner Electrolyte Metab 1988; 14: 240–5.

Breuer J. , Moniz C. , Baldwin D. , Parsons V. The effects of zero magnesium dialysate and magnesium supplements on ionized calcium concentration in patients on regular dialysis treatment. Nephrol Dial Transplant 1987; 2: 347–50.

Shah G. , Winer R. , Cutler R. Effects of magnesium free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1987; 10(4): 268–75.

Dyckner T. , Webster P. Relation between potassium and magnesium in cardiac arrhythmias. Acta Med Scand 1981; 647(Suppl): 163–9.

Seelig M. Electrocardiographic patterns of magnesium depletion appearing in alcoholic heart disease. Ann NY Acad Sci 1969; 162: 906–17.

Whang R. Magnesium deficiency: Pathogenesis, prevalence, and clinical implications. Am J Med 1987; 82(Suppl 3A): 24–9.

Hollifield J. Magnesium depletion, diuretics and arrhythmias. Am J Med 1987; 82(Suppl 3A): 307.